IGGI - Overview: IgG Immunostain, Technical Component Only
Classification of lymphomas and multiple myeloma
IGAI - Overview: IgA Immunostain, Technical Component Only
Aiding in the classification of lymphomas and multiple myeloma
KRT20 - Overview: Keratin 20 (KRT20) Immunostain, Technical Component Only
Aids in determining the primary site in carcinomas of unknown origin
KI67P - Overview: Ki-67(MIB-1), Pulmonary, Quantitative Immunohistochemistry, Automated
Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with carcinoid or atypical carcinoid of the lung including metastases
Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with neuroendocrine tumors of the pancreas or gastrointestinal tract including metastases
KRT5 - Overview: Keratin 5 (KRT5) Immunostain, Technical Component Only
Differentiation of mesothelioma and squamous cell carcinoma versus adenocarcinoma
LANGR - Overview: Langerin Immunostain, Technical Component Only
Visualization of normal and neoplastic Langerhans cells
IGMI - Overview: IgM Immunostain, Technical Component Only
Classification of lymphomas and multiple myeloma
INHIB - Overview: Inhibin Immunostain, Technical Component Only
Identifying sex cord-stromal tumors
UIOD - Overview: Iodine, 24 Hour, Urine
Assessing iodine toxicity or recent exposure in a 24-hour urine collection Monitoring iodine excretion rate as index of replacement therapy
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...